1307853-38-8

Basic information

• Product Name: {2'-[1-(p-methoxybenzyl)-1H-tetrazol-5-yl]biphenyl-4-yl}-methanol
• Synonyms: {2'-[1-(p-methoxybenzyl)-1H-tetrazol-5-yl]biphenyl-4-yl}-methanol
• CAS NO: 1307853-38-8
• Molecular Weight: 372.426
• Mol File: 1307853-38-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: {2'-[1-(p-methoxybenzyl)-1H-tetrazol-5-yl]biphenyl-4-yl}-methanol(CAS DataBase Reference)
• NIST Chemistry Reference: {2'-[1-(p-methoxybenzyl)-1H-tetrazol-5-yl]biphenyl-4-yl}-methanol(1307853-38-8)
• EPA Substance Registry System: {2'-[1-(p-methoxybenzyl)-1H-tetrazol-5-yl]biphenyl-4-yl}-methanol(1307853-38-8)

Safety Data

• Hazardous Substances Data: 1307853-38-8(Hazardous Substances Data)

Upstream product

• 873-75-6 4-bromobenzenemethanol 
• 21388-92-1 4-bromobenzyl acetate 
• 824-94-2 p-methoxybenzyl chloride 
• 2393-23-9 4-methoxy-benzylamine 
• 98-88-4 benzoyl chloride 
• 41882-10-4 N-(4-methoxybenzyl)benzamide 
• 1301606-98-3 {2'-{1-(p-methoxybenzyl)-1H-tetrazol-5-yl}biphenyl-4-yl}methyl acetate 
• 512182-38-6 1-(p-methoxybenzyl)-5-phenyl-1H-tetrazole 
• 18039-42-4 5-Phenyl-1H-tetrazole 

Downstream Products

• 1307853-51-5 2-butyl-4-chloro-1-({2'-[1-(p-methoxybenzyl)-1H-tetrazol-5-yl]-biphenyl-4-yl}-methyl)imidazole-5-carbaldehyde 
• 1307853-52-6 2-butyl-4-chloro-1-({2'-[1-(p-methoxybenzyl)-1H-tetrazol-5-yl]-biphenyl-4-yl}-methyl)imidazole-5-methanol 
• 1307853-40-2 5-[4'-(bromomethyl)biphenyl-2-yl]-1-(p-methoxybenzyl)-1H-tetrazole 
• 114798-36-6 2-n-Butyl-4-chloro-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-imidazole-5-carboxaldehyde 
• 114798-26-4 lorsartan 
• 137862-53-4 N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine 
• 1307853-79-7 C₄₁H₄₂N₆O₇ 
• 1307853-73-1 C₃₃H₃₀N₆O₄ 
• 145040-37-5 candesartan cilexetil 

Relevant articles and documents

PROCESS FOR PRODUCTION OF BIPHENYL DERIVATIVE

The invention provides a production method of a biaryltetrazole derivative useful as an intermediate for an angiotensin II receptor antagonist. The method comprises reacting an aryltetrazole derivative with a benzene derivative, deprotecting or reducing the resulting compound, and halogenating the deprotected or reduced compound